Allergic and Nonallergic Asthma Have Distinct Phenotypic and Genotypic Features

Carregando...
Imagem de Miniatura
Citações na Scopus
17
Tipo de produção
article
Data de publicação
2017
Editora
KARGER
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, v.172, n.3, p.150-160, 2017
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Identification of asthma phenotypes enables a better understanding and management of this heterogeneous disease. Studies have reported associations between human leukocyte antigens (HLA) and asthma in different populations, but the results have been inconclusive and they have rarely considered the distinct disease phenotypes. Our objective was to characterize allergic and nonallergic asthma phenotypes and evaluate possible associations with the HLA system. Methods: A total of 109 patients with asthma were prospectively followed during 2 years. They were divided into 2 groups, i.e., allergic and nonallergic asthma, according to their clinical history and skin prick test and serum-specific immunoglobulin E (IgE) results. The control group comprised 297 deceased donors of solid organs. Patients' features and HLA class I and II genotypes were assessed and compared. Results: This study showed different features between asthma phenotypes. Nonallergic patients were older at the onset of asthma symptoms and had a higher rate of intolerance to nonsteroidal anti-inflammatory drugs. Allergic patients had higher total serum IgE levels, reported atopic dermatitis and rhinoconjunctivitis more frequently, and, unexpectedly, had a greater disease severity. New associations between the HLA genotypes and allergic and nonallergic asthma were identified. The HLA-B*42, HLA-C*17, HLA-DPA1*03, and HLA-DPB1*105 genotypes were associated with allergic asthma and the HLA-B*48 genotype with the nonallergic phenotype. The presence of the haplotype HLA-DPA1*03 DQA*05 was associated with allergic asthma, and the presence of HLA-DPA1*03 and the absence of HLA-DQA*05 with nonallergic asthma. Conclusions: Allergic and nonallergic asthma have distinct phenotypic and genotypic features. New associations between asthma phenotypes and HLA class I and II were identified. (C) 2017 S. Karger AG, Basel
Palavras-chave
Asthma, Human leukocyte antigens, Allergic asthma, Nonatopic
Referências
  1. Abraham B, 2003, EUR RESPIR J, V22, P470, DOI 10.1183/09031936.03.00261903
  2. Apostolakis J, 1996, RESP MED, V90, P201, DOI 10.1016/S0954-6111(96)90287-5
  3. Bousquet PJ, 2015, INT ARCH ALLERGY IMM, V166, P231, DOI 10.1159/000381339
  4. Bradding P, 2010, CURR OPIN ALLERGY CL, V10, P54, DOI 10.1097/ACI.0b013e32833489a9
  5. Breiman L., 1984, CLASSIFICATION REGRE
  6. BROSTOFF J, 1976, LANCET, V2, P872
  7. Brunner E, 2000, BIOMETRICAL J, V42, P17, DOI 10.1002/(SICI)1521-4036(200001)42:1<17::AID-BIMJ17>3.0.CO;2-U
  8. CARABALLO L, 1991, HUM IMMUNOL, V32, P157, DOI 10.1016/0198-8859(91)90051-A
  9. Charpin D, 2003, J ASTHMA, V40, P87, DOI 10.1081/JAS-120017211
  10. Comi AL, 2007, RESP MED, V101, P2526, DOI 10.1016/j.rmed.2007.07.010
  11. DiCiccio TJ, 1996, STAT SCI, V11, P189
  12. Dombrowicz D, 2002, IGE ANTI IGE THERAPY, P69
  13. Esmaeilzadeh H, 2015, AM J RHINOL ALLERGY, V29, pE63, DOI 10.2500/ajra.2015.29.4154
  14. Gao JM, 2003, CHINESE MED J-PEKING, V116, P1078
  15. Giavina-Bianchi P, 2015, J ALLERGY CLIN IMMUN, V135, P151, DOI 10.1016/j.jaci.2014.10.029
  16. Giavina-Bianchi P, 2013, J ALLERGY CLIN IMMUN, V131, P1261, DOI 10.1016/j.jaci.2013.01.050
  17. Haldar P, 2008, AM J RESP CRIT CARE, V178, P218, DOI [10.1164/rccm.200711-1754OC, 10.1164/rccm.200711-17540C]
  18. Hallstrand T, 2001, CLIN IMMUNOLOGY PRIN
  19. Heck S, 2015, INT ARCH ALLERGY IMM, V168, P241, DOI 10.1159/000443930
  20. HSIEH KH, 1991, TISSUE ANTIGENS, V38, P181, DOI 10.1111/j.1399-0039.1991.tb01893.x
  21. Ivkovic-Jurekovic I, 2011, COLLEGIUM ANTROPOL, V35, P1243
  22. Jenkins HA, 2003, CHEST, V124, P1318, DOI 10.1378/chest.124.4.1318
  23. Johansson SGO, 2001, ALLERGY, V56, P813, DOI 10.1034/j.1398-9995.2001.t01-1-00001.x
  24. Johansson SGO, 2004, J ALLERGY CLIN IMMUN, V113, P832, DOI 10.1016/j.jaci.2003.12.591
  25. Kontakioti E, 2014, HUM IMMUNOL, V75, P930, DOI 10.1016/j.humimm.2014.06.022
  26. Lara-Marquez ML, 1999, CLIN EXP ALLERGY, V29, P60
  27. LEOPOLD HC, 1965, J ALLERGY, V36, P175, DOI 10.1016/0021-8707(65)90165-6
  28. Leung DYM, 2004, J ALLERGY CLIN IMMUN, V113, P1
  29. Li XN, 2010, J ALLERGY CLIN IMMUN, V125, P328, DOI 10.1016/j.jaci.2009.11.018
  30. Lockey RF, 2014, J ALLER CL IMM-PRACT, V2, P682, DOI 10.1016/j.jaip.2014.09.008
  31. MACEK V, 1994, AM J RESP CRIT CARE, V150, P7
  32. MARSH DG, 1981, NEW ENGL J MED, V305, P1551, DOI 10.1056/NEJM198112243052603
  33. Martyn MB, 2010, ALLERGY ASTHMA PROC, V31, P120, DOI 10.2500/aap.2010.31.3321
  34. Menz G, 1998, ALLERGY, V53, P15
  35. Miranda C, 2004, J ALLERGY CLIN IMMUN, V113, P101, DOI 10.1016/j.jaci.2003.10.041
  36. Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312
  37. MOLONEY JR, 1980, CLIN OTOLARYNGOL, V5, P183, DOI 10.1111/j.1365-2273.1980.tb01645.x
  38. Moore WC, 2007, J ALLERGY CLIN IMMUN, V119, P405, DOI 10.1016/j.jaci.2006.11.639
  39. Moore WC, 2010, AM J RESP CRIT CARE, V181, P315, DOI 10.1164/rccm.200906-0896OC
  40. Morris M J, 1977, Monogr Allergy, V11, P30
  41. MORRIS MJ, 1980, CLIN ALLERGY, V10, P173, DOI 10.1111/j.1365-2222.1980.tb02094.x
  42. Nahm DH, 2001, J KOREAN MED SCI, V16, P407
  43. Noguchi E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002170
  44. OSTERGAARD PA, 1979, EUR J PEDIATR, V131, P263, DOI 10.1007/BF00444347
  45. Parapanissiou E, 2005, TISSUE ANTIGENS, V65, P481, DOI 10.1111/j.1399-0039.2005.00392.x
  46. Pillai P, 2011, ISRN ALLERGY, V2011
  47. RACKEMANN FM, 1947, AM J MED, V3, P601, DOI 10.1016/0002-9343(47)90204-0
  48. Romanet-Manent S, 2002, ALLERGY, V57, P607, DOI 10.1034/j.1398-9995.2002.23504.x
  49. SETTIPANE GA, 1977, J ALLERGY CLIN IMMUN, V59, P17, DOI 10.1016/0091-6749(77)90171-3
  50. SIBBALD B, 1979, THORAX, V34, P332, DOI 10.1136/thx.34.3.332
  51. Smit LAM, 2014, EUR RESPIR J, V44, P1234, DOI 10.1183/09031936.00068014
  52. Sociedade Brasileira de Pneumologia e Tisiologia, 2002, J PNEUMOL, V28, P1
  53. SZCZEKLIK A, 1995, AM J RESP CRIT CARE, V152, P1753
  54. THORSBY E, 1971, Tissue Antigens, V1, P147
  55. Toledo M F, 2016, Allergol Immunopathol (Madr), V44, P439, DOI 10.1016/j.aller.2016.02.006
  56. Torio A, 2000, EUR J IMMUNOGENET, V27, P81, DOI 10.1046/j.1365-2370.2000.00205.x
  57. TURTON CWG, 1979, THORAX, V34, P670, DOI 10.1136/thx.34.5.670
  58. ULRIK CS, 1992, J ASTHMA, V29, P29, DOI 10.3109/02770909209110638
  59. WANG WX, 1988, TISSUE ANTIGENS, V32, P215, DOI 10.1111/j.1399-0039.1988.tb01658.x